MedPath

Comparison of two oral drugs for ovulation in women with unexplained infertility: Randomised Control Trial.

Phase 4
Conditions
Health Condition 1: N979- Female infertility, unspecified
Registration Number
CTRI/2024/07/071335
Lead Sponsor
Deepika Singh
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Women with unexplained infertility (whether primary or secondary in which couple fails to achieve pregnancy after 1 year of unprotected and regular intercourse) with following criteria:

1 Normal husband semen analysis

2 Patent fallopian tube on HSG/ chromopertubation

3 Normal uterine cavity on USG

4 Normal ovulatory function.

Exclusion Criteria

Patients with any of the following:

1 Hormonal imbalance (hypothyroidism, insulin resistance and hyperprolactinemia)

2 History of ovarian or uterine tumour

3 AFC less than 5, AMH less than 1ng/ml

4 BMI greater than 35kg/m2 or higher

5 Resistance to clomiphene citrate or tamoxifen

6 Predicted decreased endometrial receptivity ,intrauterine abnormalities, adhesions and chronic endometritis, uterine polyp or submucosal fibroid).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath